- 1) Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., and Witztum, J. L., Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New Engl. J. Med., 320, 915-924 (1989).
- 2) Daugherty, A., and Roselaar, S. E., Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies. Cardiovascular Research, 29, 297-311 (1995).
- 3) Itabe, H., Yamamoto, H., Imanaka, T., Shimahara, K., Uchiyama, H., Kimura, J., Sanaka, T., Hata, Y., and Takano, T., Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J. Lipid Research, 37, 45-53 (1996).
- 4) Holvoet, P., and Collen, D., Oxidation of low density lipoprotein in the pathogenesis of atherosclerosis. Atherosclerosis, 137 Suppl., S33-S38 (1998).
- 5) Jessup, W., Rankin, S. M., De Whalley, C. V., Hoult, J. R. S., Scott, J., and Leake, D. S., Alfa-tocopherol consumption during low-density-lipoprotein oxidation. Biochem. J., 265, 399-405 (1990).
- 6) Frei, B., England, L., and Ames, B. N., Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA, 86, 6377-6381 (1989).
- 7) Carpenter, K. L. H., Van der Veen, C., Hird, R., Dennis, I. F., Ding, T., and Mitchinson, M. J., The carotenoids beta-carotene, canthaxanthin and zeaxanthin inhibit macrophage-mediated LDL oxidation. FEBS Letters, 401, 262-266 (1997).
- 8) Oshima, S., Ojima, F., Sakamoto, H., Ishiguro, Y., and Terao, J., Supplementation with carotenoids inhibits singlet oxygen-mediated oxidation of human plasma low-density lipoprotein. J. Agric. Food Chem., 44, 2306-2309 (1996).
- 9) Miura, S., Watanabe, J., Tomita, T., Sano, M., and Tomita, I., The inhibitory effects of tea polyphenols (flavan-3-ol derivatives) on Cu2+ mediated oxidative modification of low density lipoprotein. Biol. Pharm. Bull., 17, 1567-1572 (1994).
- 10) Choi, H. S., Song, H. S., Ukeda, H., and Sawamura, M., Radical-scavenging activities of citrus essential oils and their components: Detection using 1,1-diphenyl-2-picrylhydrazyl. J. Agric. Food Chem., 48, 4156-4161 (2000).
- 11) Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the Folin phenol reagents. J. Biol. Chem., 193, 265-275 (1951).
- 12) Yagi, K., A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med., 15, 212-216 (1976).
- 13) Esterbauer, H., Striegl, G., Puhl, H., and Rotheneder, M., Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Comms., 6, 67-75 (1988).
- 14) Frei, B., and Gaziano, J. M., Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and-independent oxidation. J. Lipid Research, 34, 2135-2145 (1993).
- 15) Yamanaka, N., Oda, O., and Nagao, S., Prooxidant activity of caffeic acid, dietary non-flavonoid phenolic acid, on Cu2+-induced low density lipoprotein oxidation. FEBS Letters, 405, 186-190 (1997).
Bioscience, Biotechnology, and Biochemistry
Volume 67, 2003 - Issue 1